Advanced Enzyme Technologies has informed that the Board of Directors in its meeting held on March 23, 2019 has approved the amended (i) Insider Trading Code of the Company; and (ii) Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) [both the amended Codes are effective from April 01, 2019. Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulation, 2015 (as amended), copy of the amended Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information is enclosed. The above Codes are also being uploaded on the website of the Company (www.advancedenzymes.com).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: